1.A Combined Protocol of Chinese Herbal Medicine and Acupuncture for Chronic Gastritis
Ningxia ZHAO ; Yinhu XIN ; Qinyou REN
Journal of Zhejiang Chinese Medical University 2006;0(05):-
[Objective] To evaluate the clinical curative effect of a combined protocol using Chinese herbal medicine and acupuncture for chronic gastritis.[Methods] 23 patients used the Chinese medicine only(group 1)and 65 patients received the combined protocol(2).Clinical symptoms and gastroscopic findings before and after treatment were recorded and analyzed.[Results] The clinical symptoms improved greatly in 15 of the group 1,with an overall curative rate 65%,and in 62 of the group 2 with an overall curative rate 95%.The difference between the 2 groups was significant.[Conclusion] The combined use of Chinese medicine and the needle medicine is preferable to single use of Chinese medicine for chronic gastritis.
2.Protective Role of Fucoidan in Cerebral Ischemia-Reperfusion Injury through Inhibition of MAPK Signaling Pathway.
Nan CHE ; Yijie MA ; Yinhu XIN
Biomolecules & Therapeutics 2017;25(3):272-278
Fucoidan has been reported to exhibit various beneficial activities ranging from to antivirus and anticancer properties. However, little information is available about the effects of fucoidan on cerebral ischemia-reperfusion injury (IRI). Our study aimed to explore the effects of fucoidan on cerebral IRI, as well as the underlying mechanisms. Sprague-Dawley (SD) rats were randomly subjected to four groups: Sham, IRI+saline (IRI+S), IRI+80 mg/kg fucoidan (IRI+F80), and IRI+160 mg/kg fucoidan (IRI+F160). Fucoidan (80 mg/kg or 160 mg/kg) was intraperitoneally injected from 7 days before the rats were induced to cerebral IRI model with middle cerebral artery occlusion (MCAO) method. At 24 h after reperfusion, neurological deficits and the total infarct volume were determined. The levels of inflammation-associated cytokines (interleukin (IL)-1β, IL-6, myeloperoxidase (MPO), and tumor necrosis factor (TNF)-α), oxidative stress-related proteins (malondialdehyde (MDA) and superoxide dismutase (SOD)) in the ischemic brain were measured by enzyme-linked immunosorbent assay (ELISA). Besides, the levels of apoptosis-related proteins (p-53, Bax, and B-cell lymphoma (Bcl)-2) and mitogen-activated protein kinase (MAPK) pathway (phosphorylation-extracellular signal-regulated kinase (p-ERK), p-c-Jun N-terminal kinase (JNK), and p-p38) were measured. Results showed that administration of fucoidan significantly reduced the neurological deficits and infarct volume compared to the IRI+S group in a dose-dependent manner. Also, fucoidan statistically decreased the levels of inflammation-associated cytokines, and oxidative stress-related proteins, inhibited apoptosis, and suppressed the MAPK pathway. So, Fucoidan plays a protective role in cerebral IRI might be by inhibition of MAPK pathway.
Animals
;
Apoptosis
;
Brain
;
Cytokines
;
Enzyme-Linked Immunosorbent Assay
;
Infarction, Middle Cerebral Artery
;
Interleukin-6
;
Lymphoma, B-Cell
;
Methods
;
Peroxidase
;
Phosphotransferases
;
Protein Kinases
;
Rats
;
Rats, Sprague-Dawley
;
Reperfusion
;
Reperfusion Injury*
;
Superoxide Dismutase
;
Tumor Necrosis Factor-alpha
3.Endothelial dysfunction induced by high glucose is associated with decreased ATP-binding cassette transporter G1 expression.
Jiahong XUE ; Xiaolin NIU ; Jin WEI ; Xin DONG ; Canzhan ZHU ; Yinhu DANG ; Anqi SONG ; Huimei HUANG
Journal of Southern Medical University 2012;32(1):14-18
OBJECTIVETo investigate the role of ATP-binding cassette transporter G1 (ABCG1) in endothelial dysfunction induced by high glucose.
METHODSHuman aortic endothelial cells (HAECs) were incubated in the presence of 5.6 or 30 mmol/L glucose for 24-72 h with or without a 2-h pretreatment with the LXR agonist 22(R)-hydroxycholesterol. Real-time PCR and Western blotting were used to measure the mRNA and protein expressions of ABCG1; the intracellular cholesterol efflux and endothelial nitric oxide synthase (eNOS) activity were measured by scintillation counting.
RESULTSHigh glucose time-dependently suppressed ABCG1 expression and cholesterol efflux to HDL in HAECs. High glucose also decreased eNOS activity. ABCG1 down-regulation induced by high glucose, along with decreased cholesterol efflux and eNOS activity, was abolished by treatment of the cells with the LXR agonist.
CONCLUSIONEndothelial dysfunction induced by high glucose is associated with decreased ABCG1 expression.
ATP Binding Cassette Transporter, Sub-Family G, Member 1 ; ATP-Binding Cassette Transporters ; genetics ; metabolism ; Aorta ; cytology ; Cell Line ; Down-Regulation ; drug effects ; Endothelial Cells ; cytology ; metabolism ; physiology ; Glucose ; pharmacology ; Humans